Clinical Trial

Clinical Implication of Atrial Fibrillation Detection Using Wearable Device in Patients With Cryptogenic Stroke

Study acronym: CANDLE-AF
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
It is known that atrial fibrillation after stroke significantly increases the risk of stroke or systemic embolism. Accordingly, efforts have been made to detect hidden atrial fibrillation and apply treatment using anticoagulants instead of antiplatelet agents. The conventional method used to screen for atrial fibrillation in stroke patients who did not have atrial fibrillation at first admission is 24-hour Holter monitoring. This study will compare the detection rate of atrial fibrillation with discontinuous ECG monitoring three times a day and 72 hours of single-lead ECG patch monitoring compared with the conventional Holter test.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2020-11-05; most recent amendment 2026-05-17.
Status change: Recruiting → Active, Not Recruiting 2026-05-17
Status change: Withheld → Recruiting 2023-01-16
Trial Details
NCT Number NCT04624646
Lead Sponsor Ewha Womans University Mokdong Hospital
Collaborators: Korea Health Industry Development Institute
Conditions Atrial Fibrillation, Ischemic Stroke, Transient Ischemic Attack
Enrollment 337 participants
Start Date 2020-11-17
Primary Completion 2025-11-01 (estimated)
Study Completion 2026-11-15 (estimated)
Updated on ClinicalTrials.gov 2026-05-20